New hope for long COVID's debilitating fatigue?
NCT ID NCT07298005
Summary
This study is testing whether an investigational drug called sonlicromanol can reduce severe fatigue in people with post-COVID condition, specifically those who experience a major worsening of symptoms after physical or mental effort (post-exertional malaise). It will involve 80 participants who will be randomly assigned to receive either the drug or a placebo pill for comparison. The main goal is to see if the drug improves fatigue levels, muscle strength, and quality of life.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST COVID CONDITION are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.